Publications by authors named "Gabriel Afram"

Claim this Profile
M
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.
Hareth Nahi, Gabriel Afram, Katarina Uttervall, Sandra Lockmer, Love Tätting

Cancer Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Caravita di Toritto and Rago.
Roza Chaireti, Katarina Uttervall, Vincent Luong, Johan Lund, Muhammad Kashif, Gabriel Afram

Eur J Haematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditioning with melphalan 200 mg/m and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.
Gabriel Afram, Roza Chaireti, Katarina Uttervall, Vincent Luong, Johan Lund

Eur J Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.
Hareth Nahi, Michael Chrobok, Stephan Meinke, Charlotte Gran, Nicole Marquardt, Gabriel Afram

Cell Rep Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involved free light chain: an early independent predictor of response and progression in multiple myeloma.
Charlotte Gran, Gabriel Afram, Johan Liwing, Andre Verhoek, Hareth Nahi

Leuk Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14).
Hareth Nahi, Muhammad Kashif, Monika Klimkowska, Maria Karvouni, Ann Wallblom, Gabriel Afram

Am J Hematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti-myeloma treatment.
Hareth Nahi, Gabriel Afram, Hanna Brauner, Toomas Talme, Natalia Kuzmina

Int J Dermatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.
Gabriel Afram, Katharina Helene Susek, Katarina Uttervall, Johanna Dehlsen Wersäll, Arnika Kathleen Wagner

Eur J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression.
Charlotte Gran, Vincent Luong, Johanna B Bruchfeld, Johan Liwing, Gabriel Afram

Am J Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
Tobias Wertheimer, Marius Dohse, Gabriel Afram, Daniela Weber, Martin Heidenreich

Ann Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study.
Erik Boberg, Lena von Bahr, Gabriel Afram, Carina Lindström, Per Ljungman

Stem Cells Transl Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis.
Gabriel Afram, Emma Watz, Mats Remberger, Ulla Axdorph Nygell, Mikael Sundin

Cent Eur J Immunol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.
Gabriel Afram, Jose Antonio Pérez Simón, Mats Remberger, Teresa Caballero-Velázquez, Rodrigo Martino

Med Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of prognostic factors among patients with chronic graft-versus-host disease.
Jose A Pérez-Simón, Gabriel Afram, Rodrigo Martino, Jose L Piñana, Teresa Caballero-Velazquez

Haematologica· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis